7. Kim SW, Her SJ, Kim SY, Shin CS (2005) Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem Biophys Res Commun 327: 811–819. 8. Justesen J, Pedersen SB, Stenderup K, Kassem M (2004) Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng 10: 381–391. 9. Sheu TJ, Schwarz EM, Martinez DA, O’Keefe RJ, Rosier RN, et al. (2003) A phage display technique identifies a novel regulator of cell differentiation. J Biol Chem 278: 438–443. 10. Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, et al. (2000) Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res 15: 103–110. 11. Lang P, Andersson G (2005) Differential expression of monomeric and proteolytically processed forms of tartrate-resistant acid phosphatase in rat tissues. Cell Mol Life Sci 62: 905–918. 12. Ljusberg J, Ek-Rylander B, Andersson G (1999) Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. Biochem J 343 Pt 1: 63–69. 13. Ljusberg J, Wang Y, Lang P, Norgard M, Dodds R, et al. (2005) Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts. J Biol Chem 280: 28370–28381. 14. Hollberg K, Nordahl J, Hultenby K, Mengarelli-Widholm S, Andersson G, et al. (2005) Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix- resorbing clasts. J Bone Miner Metab 23: 441–449. 15. Reinholt FP, Widholm SM, Ek-Rylander B, Andersson G (1990) Ultrastructural localization of a tartrate-resistant acid ATPase in bone. J Bone Miner Res 5: 1055–1061. 16. Janckila AJ, Parthasarathy RN, Parthasarathy LK, Seelan RS, Hsueh YC, et al. (2005) Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells. J Leukoc Biol 77: 209–218. 17. Halleen J, Raisanen S, Salo J, Reddy S, Roodman G, et al. (1999) Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274: 22907–22910. 18. Va¨a¨rniemi J, Halleen JM, Kaarlonen K, Ylipahkala H, Alatalo SL, et al. (2004) Intracellular machinery for matrix degradation in bone resorbing osteoclasts. J Bone Miner Res 19: 1932–1940. 19. Raisanen SR, Halleen J, Parikka V, Vaananen HK (2001) Tartrate-resistant acid phosphatase facilitates hydroxyl radical formation and colocalizes with phagocytosed Staphylococcus aureus in alveolar macrophages. Biochem Biophys Res Commun 288: 142–150. 20. Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sjolander J, Lang P, et al. (2003) TRACP as an osteopontin phosphatase. J Bone Miner Res 18: 1912–1915. 21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796–1808. 22. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821–1830. 23. Permana PA, Menge C, Reaven PD (2006) Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341: 507–514. 24. Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K (2007) Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148: 868–877. 25. Constant VA, Gagnon A, Landry A, Sorisky A (2006) Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49: 1402–1411. 26. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, et al. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447: 1116–1120. 27. Walsh NC, Cahill M, Carninci P, Kawai J, Okazaki Y, et al. (2003) Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene. Gene 307: 111–123. 28. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, et al. (2005) Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 8: 347–354. 29. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, et al. (1993) Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268: 22243–22246. 30. Valet P, Senard JM, Devedjian JC, Planat V, Salomon R, et al. (1993) Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa. J Clin Invest 91: 2049–2057. 31. Hayman AR, Cox TM (2003) Tartrate-resistant acid phosphatase knockout mice. J Bone Miner Res 18: 1905–1907. 32. Suzuki K, Ishida H, Takeshita N, Taguchi Y, Sugimoto C, et al. (1998) Circulating levels of tartrate-resistant acid phosphatase in rat models of non- insulin-dependent diabetes mellitus. J Diabetes Complications 12: 176–180. 33. Zenger S, Hollberg K, Ljusberg J, Norgard M, Ek-Rylander B, et al. (2007) Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice. Bone 5: 820–832. TRAP Induces Obesity 34. Chiellini C, Costa M, Novelli SE, Amri EZ, Benzi L, et al. (2003) Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol 195: 309–321. 35. Funicello M, Novelli M, Ragni M, Vottari T, Cocuzza C, et al. (2007) Cathepsin K mice show reduced adiposity during the rapid accumulation of fat stores. PLoS ONE 2: e683. 36. Xiao Y, Junfeng H, Tianhong L, Lu W, Shulin C, et al. (2006) Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity. J Clin Endocrinol Metab 91: 4520–4527. 37. Brook CG, Lloyd JK, Wolf OH (1972) Relation between age of onset of obesity and size and number of adipose cells. Br Med J 2: 25–27. 38. Bonnet FP, Rocour-Brumioul D, Heuskin A (1979) Regional variations of adipose cell size and local cellularity in human subcutaneous fat during normal growth. Acta Paediatr Belg 32: 17–27. 39. Hirsch J, Fried SK, Edens NK, Leibel RL (1989) The fat cell. Med Clin North Am 73: 83–96. 40. Bazer FW, Worthington-White D, Fliss MF, Gross S (1991) Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin. Exp Hematol 19: 910–915. 41. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911–919; quiz 920. 42. Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785–1788. 43. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46: 2347–2355. 44. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, et al. (2006) Overexpression of MCP-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 36: 26602–26614. 45. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494–1505. 46. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AS, et al. (2005) A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 90: 5834–5840. 47. Hayman A, Bune A, Bradley J, Rashbass J, Cox T (2000) Osteoclastic tartrate- resistant acid phophatase (Acp 5): its to dendritic cells and diverse murine tissues. J Histochem Cytochem 48: 219–228. 48. Hayman AR, Macary P, Lehner PJ, Cox TM (2001) Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells. J Histochem Cytochem 49: 675–684. 49. Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, et al. (2004) Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 63: 774–784. 50. Partington GA, Fuller K, Chambers TJ, Pondel M (2004) Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation. Bone 34: 237–245. 51. Wang Y, Andersson G (2007) Expression and proteolytic processing of mammalian purple acid phosphatase in CHO-K1 cells. Arch Biochem Biophys 461: 85–94. 52. Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67: 968–977. 53. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, et al. (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54: 254–260. 54. Salans LB, Knittle JL, Hirsch J (1968) The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest 47: 153–165. 55. Stern JS, Batchelor BR, Hollander N, Cohn CK, Hirsch J (1972) Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet 2: 948–951. 56. Brook CG, Lloyd JK (1973) Adipose cell size and glucose tolerance in obese children and effects of diet. Arch Dis Child 48: 301–304. 57. Salans LB, Cushman SW, Weismann RE (1973) Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest 52: 929–941. 58. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE (2000) Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43: 1498–1506. 59. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, et al. (2006) Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. Faseb J 20: 1540–1542. 60. Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, et al. (2003) Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149: 129–135. 61. Arner P (2003) The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14: 137–145. 62. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, et al. (2006) TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116: 2791–2798. PLoS ONE | www.plosone.org 13 March 2008 | Volume 3 | Issue 3 | e1713